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A PEGDA (polyethylene glycol
diacrylate) hydrogel coating
containing PMMAcoMA
[poly(methyl methacrylate-co-
methacrylic acid)] will be used
for the delivery of Memantine.
This drug delivery system will
be used to enhance pH
reactivity and prolong
digestion. pH sensitivity will
prevent the drug from releasing
within the stomach where
minimal absorption occurs.
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Alzheimer’s disease (AD) drugs are commonly administered
orally, requiring passage through the gastrointestinal (GI)
tract before entering the bloodstream. While in the GI tract,
much of the drug is broken down by catalytic enzymes before
being reabsorbed by the small intestines or denatured due to
the varying levels of pH. Orally ingested drugs are
predominantly excreted from the body, making the design of
a high efficacy delivery system a priority.
Enhance the delivery of Memantine through the GI tract to 
increase drug bioavailability
Once entering the duodenum of the small intestine, the rise
in pH will cause the hydrogel to swell and release the drug.
This will lead to subsequent digestion and absorption in the
small intestine.
FITC, a fluorescent dye, was used to mimic Memantine in
the PEGDA hydrogels and were placed in separate vials
containing different pH levels found in the GI Tract.
NanoDrop Spectrophotometry was used to determine the
amount of fluorescence in each vial after varying time points.
Figure 2: PEGDA hydrogel prior to
UV catalysis (Left). PEGDA
hydrogel during UV catalysis
(Middle). PEGDA hydrogel after 30
minutes of UV catalysis (Right)
Figure 1: pH levels in the GI Tract Figure 3: Average relative fluorescence over time at various pH levels
Fluorescent release was found to be maximum at a pH of 7.4 
followed by a pH of 6, 5, 4, and 3 respectively.
In all of the trials testing the PEGDA/PMMA-co-MA hydrogel, 
the drug delivery system demonstrated the desired decrease 
in swelling with decrease in solution pH, assessed using 
fluorescent FITC as the model for the drug. The design allows 
for the desired drug, memantine, to be carried through the 
acidic environment of the stomach to be released ultimately 
in the small intestine where the pH increases. This expected 
change in swelling due to changes in pH is due to PMMA-co-
MA’s anionic nature that carries a charge in less acidic 
environments to allow swelling and release of its contents. 
Although the desired correlation was observed between 
swelling and pH, the design can be improved by adjusting the 
polymer ratios to minimize swelling at more acidic pHs. 
Further experimentation could also include replacing the 
FITC in the design with the actual drug of choice.
Figure 4: The dehydrated hydrogel displayed RFU values well below the respective values 
for the hydrated hydrogel. The overall relationship; however, remains the same in both 
sets of data.
We thank Dr. Hu Yang, VCU School of Engineering, and the Department of Biomedical Engineering
